Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230568
Status:
COMPLETED
Last Update Posted:
2011-04-01
First Post:
2005-09-29
Brief Title:
EARTH 413 A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimers Disease AD
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Study Overview
Official Title:
A 12-Week Multicenter Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride Aricept in Hispanic Patients With Mild to Moderate Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
12-week open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimers Disease AD in the US
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None